REGENXBIO Inventory Turnover Ratio 2014-2019 | RGNX

REGENXBIO inventory turnover ratio from 2014 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
REGENXBIO Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.468B $0.219B
REGENXBIO Inc. is a biotechnology company. The Company focuses on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy. Its products candidates include RGX-501, for the treatment of homozygous familial hypercholesterolemia which uses the AAV8 vector to deliver the human low-density lipoprotein receptor gene to liver cells; RGX-111, for the treatment of Mucopolysaccharidosis Type I which uses the AAV9 vector to deliver the human a-l-iduronidase gene to the central nervous system; RGX-121, for the treatment of Mucopolysaccharidosis Type II; RGX-314, for the treatment of wet age-related macular degeneration and RGX-321, for the treatment of X-linked retinitis pigmentosa. REGENXBIO Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.380B 15.13
Gilead Sciences (GILD) United States $82.715B 10.25
CSL (CSLLY) Australia $82.366B 0.00
Celgene (CELG) United States $77.961B 11.13
Biogen (BIIB) United States $52.915B 9.08
Vertex Pharmaceuticals (VRTX) United States $51.767B 52.84
Illumina (ILMN) United States $43.128B 47.32
Regeneron Pharmaceuticals (REGN) United States $37.539B 16.43
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.517B 12.11
Seattle Genetics (SGEN) United States $18.568B 0.00
Incyte (INCY) United States $18.330B 42.55
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.254B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.634B 0.00
Genmab (GNMSF) Denmark $13.346B 74.86
Exact Sciences (EXAS) United States $10.862B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Alnylam Pharmaceuticals (ALNY) United States $10.372B 0.00
Galapagos (GLPG) Belgium $10.348B 26.66
BeiGene (BGNE) Cayman Islands $9.470B 0.00
Bio-Techne Corp (TECH) United States $7.745B 51.84
Sarepta Therapeutics (SRPT) United States $7.177B 0.00
QIAGEN (QGEN) Netherlands $7.128B 23.24
Guardant Health (GH) United States $6.683B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.563B 0.00
Reata Pharmaceuticals (RETA) United States $6.370B 0.00
Amarin (AMRN) Ireland $6.244B 0.00
Moderna (MRNA) United States $5.829B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.525B 14.05
ARGENX SE-ADR (ARGX) Netherlands $4.861B 0.00
Exelixis (EXEL) United States $4.792B 13.48
Ascendis Pharma (ASND) Denmark $4.780B 0.00
China Biologic Products (CBPO) China $4.566B 28.50
Medicines (MDCO) United States $4.386B 0.00
Repligen (RGEN) United States $4.378B 79.33
Bluebird Bio (BLUE) United States $4.314B 0.00
Spark Therapeutics (ONCE) United States $4.294B 0.00
Mirati Therapeutics (MRTX) United States $4.132B 0.00
Blueprint Medicines (BPMC) United States $3.605B 0.00
Adaptive Biotechnologies (ADPT) United States $3.429B 0.00
MorphoSys AG (MOR) Germany $3.410B 0.00
Immunomedics (IMMU) United States $3.376B 0.00
Alkermes (ALKS) Ireland $3.168B 0.00
Genmab (GMAB) Denmark $2.843B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.790B 0.00
Emergent Biosolutions (EBS) United States $2.790B 27.71
MyoKardia (MYOK) United States $2.774B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.709B 0.00
Halozyme Therapeutics (HALO) United States $2.468B 0.00
Arena Pharmaceuticals (ARNA) United States $2.362B 5.52
NeoGenomics (NEO) United States $2.357B 126.06
UniQure (QURE) Netherlands $2.339B 0.00
Acceleron Pharma (XLRN) United States $2.297B 0.00
Amicus Therapeutics (FOLD) United States $2.276B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.247B 0.00
RA PHARMCTL INC (RARX) United States $2.201B 0.00
Zai Lab (ZLAB) China $2.185B 0.00
Ligand Pharmaceuticals (LGND) United States $2.068B 36.76
Cambrex (CBM) United States $2.017B 25.45
Akcea Therapeutics (AKCA) United States $1.813B 0.00
Myriad Genetics (MYGN) United States $1.759B 25.98
Insmed (INSM) United States $1.704B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.623B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.519B 0.00
Denali Therapeutics (DNLI) United States $1.423B 0.00
Epizyme (EPZM) United States $1.383B 0.00
Zymeworks (ZYME) Canada $1.349B 0.00
Coherus BioSciences (CHRS) United States $1.330B 0.00
Innoviva (INVA) United States $1.266B 3.73
Dicerna Pharmaceuticals (DRNA) United States $1.211B 0.00
Alector (ALEC) United States $1.178B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.145B 0.00
Zealand Pharma (ZLDPF) Denmark $1.143B 0.00
Sangamo Therapeutics (SGMO) United States $1.142B 0.00
Fate Therapeutics (FATE) United States $1.104B 0.00
Zealand Pharma (ZEAL) Denmark $1.025B 11.50
Editas Medicine (EDIT) United States $1.015B 0.00
WAVE Life Sciences (WVE) Singapore $0.950B 0.00
Athenex (ATNX) United States $0.923B 0.00
Codexis (CDXS) United States $0.907B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.891B 0.00
Arvinas (ARVN) United States $0.861B 0.00
Anika Therapeutics (ANIK) United States $0.859B 27.88
Cara Therapeutics (CARA) United States $0.848B 0.00
Vericel (VCEL) United States $0.840B 313.33
ZIOPHARM Oncology Inc (ZIOP) United States $0.804B 0.00
Pharming Group (PHGUF) Netherlands $0.799B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.786B 6.61
Principia Biopharma (PRNB) United States $0.764B 0.00
Twist Bioscience (TWST) United States $0.735B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.734B 0.00
Heska (HSKA) United States $0.717B 183.16
Revance Therapeutics (RVNC) United States $0.699B 0.00
DBV Technologies S.A (DBVT) France $0.696B 0.00
ANI Pharmaceuticals (ANIP) United States $0.694B 11.83
MiMedx (MDXG) United States $0.652B 0.00
Intellia Therapeutics (NTLA) United States $0.643B 0.00
Mesoblast (MESO) Australia $0.602B 0.00
GENFIT S.A (GNFT) France $0.588B 0.00
Adverum Biotechnologies (ADVM) United States $0.563B 0.00
Cellectis S.A (CLLS) France $0.555B 0.00
Retrophin (RTRX) United States $0.552B 0.00
Intra-Cellular Therapies (ITCI) United States $0.529B 0.00
BioDelivery Sciences (BDSI) United States $0.518B 0.00
UROGEN PHARMA (URGN) United States $0.492B 0.00
Agenus (AGEN) United States $0.490B 0.00
Cytokineticsorporated (CYTK) United States $0.484B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.484B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.477B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.473B 0.00
PHARMA MAR SA (PHMMF) Spain $0.465B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Precision BioSciences (DTIL) United States $0.456B 0.00
Stemline Therapeutics (STML) United States $0.407B 0.00
Kadmon Holdings (KDMN) United States $0.390B 0.00
AC Immune SA (ACIU) Switzerland $0.380B 28.15
Lexicon Pharmaceuticals (LXRX) United States $0.374B 2.59
Merus (MRUS) Netherlands $0.367B 0.00
Prothena (PRTA) Ireland $0.362B 0.00
Puma Biotechnology (PBYI) United States $0.346B 0.00
Arcus Biosciences (RCUS) United States $0.346B 0.00
Bellus Health (BLU) Canada $0.344B 0.00
Dynavax Technologies (DVAX) United States $0.343B 0.00
Kindred Biosciences (KIN) United States $0.342B 0.00
Cellular Biomedicine (CBMG) United States $0.341B 0.00
Pfenex (PFNX) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.332B 8.31
Clovis Oncology (CLVS) United States $0.322B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.318B 0.00
Starpharma Holdings (SPHRY) Australia $0.308B 0.00
Theratechnologies (THTX) Canada $0.304B 0.00
Geron (GERN) United States $0.296B 0.00
Avid Bioservices (CDMO) United States $0.290B 0.00
Gritstone Oncology (GRTS) United States $0.279B 0.00
Compugen (CGEN) Israel $0.277B 0.00
AnaptysBio (ANAB) United States $0.275B 0.00
Protagonist Therapeutics (PTGX) United States $0.275B 0.00
CytomX Therapeutics (CTMX) United States $0.270B 0.00
Scholar Rock Holding (SRRK) United States $0.267B 0.00
Seres Therapeutics (MCRB) United States $0.258B 0.00
ADMA Biologics Inc (ADMA) United States $0.256B 0.00
Sutro Biopharma (STRO) United States $0.254B 0.00
Biofrontera AG (BFRA) Germany $0.253B 378.53
Inovio Pharmaceuticals (INO) United States $0.250B 0.00
Cel-Sci (CVM) United States $0.244B 0.00
Albireo Pharma (ALBO) United States $0.240B 0.00
MannKind (MNKD) United States $0.239B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.230B 0.00
Syros Pharmaceuticals (SYRS) United States $0.221B 0.00
Sorrento Therapeutics (SRNE) United States $0.220B 0.00
Kamada (KMDA) Israel $0.213B 8.15
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
XOMA (XOMA) United States $0.210B 0.00
OSMOTICA PHARM (OSMT) United States $0.206B 0.00
Cue Biopharma (CUE) United States $0.203B 0.00
Spero Therapeutics (SPRO) United States $0.201B 0.00
Athersys (ATHX) United States $0.199B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.193B 0.00
Exicure (XCUR) United States $0.189B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.189B 0.00
Senesco Technologies (ELOX) United States $0.179B 0.00
Palatin Technologies (PTN) United States $0.177B 5.20
ChromaDex (CDXC) United States $0.173B 0.00
Arsanis (XFOR) United States $0.167B 0.00
Dyadic (DYAI) United States $0.161B 0.00
Affimed (AFMD) Germany $0.160B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.157B 0.00
Nicox SA (NICXF) France $0.150B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.150B 0.00
Cerecor (CERC) United States $0.149B 0.00
Prometic Life Sciences (PFSCF) Canada $0.146B 0.00
Ophthotech (ISEE) United States $0.145B 0.00
Enzo Biochem (ENZ) United States $0.144B 0.00
Five Prime Therapeutics (FPRX) United States $0.142B 0.00
Alcobra (ARCT) United States $0.140B 0.00
Emmaus Life Sciences (EMMA) United States $0.136B 0.00
CorMedix Inc (CRMD) United States $0.135B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.133B 0.00
Northwest Biotherapeutics (NWBO) United States $0.131B 0.00
Abeona Therapeutics (ABEO) United States $0.130B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Menlo Therapeutics (MNLO) United States $0.125B 0.00
BioTime (LCTX) United States $0.119B 7.96
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
PHASEBIO PHARMA (PHAS) United States $0.114B 0.00
Acorda Therapeutics (ACOR) United States $0.112B 0.00
NantKwest (NK) United States $0.110B 0.00
Novavax (NVAX) United States $0.110B 0.00
Aptinyx (APTX) United States $0.108B 0.00
OvaScience (MLND) United States $0.104B 0.00
Windtree Therapeutics (WINT) United States $0.103B 0.00
Mersana Therapeutics (MRSN) United States $0.100B 0.00
Fortress Biotech (FBIO) United States $0.099B 0.00
VBI Vaccines (VBIV) United States $0.099B 0.00
Aduro Biotech (ADRO) United States $0.095B 0.00
Strongbridge Biopharma (SBBP) United States $0.095B 2.54
Adaptimmune Therapeutics (ADAP) United Kingdom $0.093B 0.00
Antibe Therapeutics (ATBPF) Canada $0.088B 0.00
Celyad SA (CYAD) Belgium $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.083B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.082B 0.00
VTv Therapeutics (VTVT) United States $0.082B 0.00
Arbutus Biopharma (ABUS) Canada $0.081B 0.00
Verastem (VSTM) United States $0.081B 0.00
Vaccinex (VCNX) United States $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.074B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Synlogic (SYBX) United States $0.073B 0.00
Trevena (TRVN) United States $0.070B 0.00
Idera Pharmaceuticals (IDRA) United States $0.069B 0.00
Catalyst Biosciences (CBIO) United States $0.069B 0.00
Checkpoint Therapeutics (CKPT) United States $0.068B 0.00
Liquidia Technologies (LQDA) United States $0.067B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.067B 0.00
Selecta Biosciences (SELB) United States $0.062B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.060B 0.00
Orgenesis (ORGS) United States $0.058B 21.18
NewLink Genetics (NLNK) United States $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.053B 0.00
Pluristem Therapeutics (PSTI) Israel $0.053B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.052B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Organovo Holdings (ONVO) United States $0.051B 0.00
Curis (CRIS) United States $0.049B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.049B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Proteostasis Therapeutics (PTI) United States $0.046B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.046B 0.00
AmpliPhi Biosciences (ARMP) United States $0.045B 0.00
AIT Therapeutics (XAIR) United States $0.045B 0.00
Clearside Biomedical (CLSD) United States $0.043B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Unum Therapeutics (UMRX) United States $0.039B 0.00
Stellar Biotechnologies (EDSA) Canada $0.037B 0.00
DiaMedica Therapeutics (DMAC) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Protalix BioTherapeutics (PLX) Israel $0.033B 0.00
VIVUS (VVUS) United States $0.031B 0.00
Celsion (CLSN) United States $0.031B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.95
Entera Bio (ENTX) Israel $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Caladrius Biosciences (CLBS) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Apricus Biosciences (SEEL) United States $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Soligenix (SNGX) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Alimera Sciences (ALIM) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.004B 0.00
Neuralstem (SNCA) United States $0.002B 0.00